Bentham Science Logo

Track Your Manuscript:


Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Letters in Drug Design & Discovery, Volume 3 - Number 4





Structural Analysis of Mogrol and its Glycosides as Inhibitors of Animal DNA Polymerase and Human Cancer Cell Growth

, 3(4): 253 - 260

Yoshiyuki Mizushina, Toshihiro Akihisa, Yousuke Hayakawa, Toshifumi Takeuchi, Isoko Kuriyama, Yuko Yonezawa, Masaharu Takemura, Ikuo Kato, Fumio Sugawara and Hiromi Yoshida


DOI: 10.2174/157018006776743224


Hologram QSAR Studies on Farnesoid X Receptor Activators

, 3(4): 261 - 267

Kathia M. Honorio, Richard C. Garratt, Igor Polikarpov and Adriano D. Andricopulo


DOI: 10.2174/157018006776743206




Pyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 Inhibitors

, 3(4): 281 - 284

Stefano Moro, Flavia Varano, Giorgio Cozza, Mario A. Pagano, Giuseppe Zagotto, Adriana Chilin, Adriano Guiotto, Daniela Catarzi, Vittoria Calotta and Lorenzo A. Pinna


DOI: 10.2174/157018006776743233



Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)

Biography
View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05

Advertisement

PLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog